POSTER: MCL-349 Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide (vipor) in Relapsed/Refractory (R/R) and Treatment-Naïve (TN) Mantle Cell Lymphoma (MCL)
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）
关键词
MCL,VIPOR,targeted therapy in lymphoma,circulating tumor DNA,minimal residual disease
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要